Novo Nordisk (spons. ADRs) Aktie

Kaufen

Verkaufen

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

51,20 EUR +0,70 EUR +1,39 %

08.10.2025

BMN

59,84 USD +0,24 USD +0,40 %

nachbörslich00:55:48

BTT

Novo Nordisk (spons. ADRs) jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Bei einem anderen Broker handeln

Smartphone

KGV26,16Div. Rendite1,37%

WKN866931

ISINUS6701002056

SymbolNVO

Novo Nordisk (spons. ADRs) Aktien News

Sortieren:Datum Meistgelesen

20.11.24MotleyFoolIs Novo Nordisk Stock a Buy Right Now?

19.11.24BenzingaNovo Nordisk Unusual Options Activity For November 19

18.11.24BenzingaNovo Nordisk To Offer Wegovy In China At Fraction Of USA Cost

18.11.24Business TimesNovo Nordisk launches obesity drug Wegovy in China

17.11.24Financial TimesNovo Nordisk readies trial results for next-generation weight-loss drug

15.11.24BenzingaThis Is What Whales Are Betting On Novo Nordisk

13.11.24BenzingaHumanitarian Organization Criticizes Eli Lilly, Novo Nordisk And Sanofi Of Having 'Double Standards' For High Insulin Price

12.11.24ZacksHere's Why Novo Nordisk (NVO) is a Strong Growth Stock

10.11.24MotleyFoolDoes This New Issue Threaten Eli Lilly and Novo Nordisk Shares?

08.11.24BenzingaBristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks

07.11.24BenzingaCompounded Versions Of Weight Loss And Diabetes Drugs Led To Death And Hospitalization, Novo Nordisk Says It Is Aware

06.11.24BenzingaForecasting The Future: 7 Analyst Projections For Novo Nordisk

06.11.24MotleyFoolNovo Nordisk (NVO) Q3 2024 Earnings Call Transcript

06.11.24MarketWatchOzempic maker Novo Nordisk nudges higher profit forecast

06.11.24Business TimesObesity drugmaker Novo Nordisk posts strong profit

06.11.24RTE.ieNovo Nordisk narrows 2024 guidance range

06.11.24Financial TimesNovo Nordisk maintains booming sales of obesity and diabetes drugs

05.11.24BenzingaNovo Nordisk Q3 Preview: Will $285 Million Weight Loss Bet Offset Bearish Charts?

04.11.24ZacksWall Street Bulls Look Optimistic About Novo Nordisk (NVO): Should You Buy?

04.11.24ZacksNovo Nordisk Before Q3 Earnings: How Should Investors Play the Stock?

04.11.24BenzingaAs Race To Best 'Miracle' Obesity Drug Heats Up, Ozempic Maker Novo Nordisk Tests New Hybrid Drug That Can Reduce Weight Up To 25%

30.10.24ZacksThe Zacks Analyst Blog Apple, Novo Nordisk, RTX and FONAR

29.10.24ZacksTop Research Reports for Apple, Novo Nordisk & RTX

29.10.24MotleyFool1 Huge New Reason to Buy Eli Lilly or Novo Nordisk Stock Right Now and Hold It Forever

28.10.24ZacksNovo Nordisk (NVO) Stock Falls Amid Market Uptick: What Investors Need to Know

28.10.24ZacksNovo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know

27.10.24MotleyFoolCould Buying This Weight Loss Stock Be Like Investing in Novo Nordisk At The Dawn of The GLP-1 Revolution?

26.10.24MotleyFoolThis Is Huge News for Novo Nordisk (Hint: It Doesn't Involve Ozempic)

24.10.24ZacksThe Zacks Analyst Blog Highlights Novo Nordisk, Novartis, Pfizer, Regeneron and Biogen

24.10.24BenzingaOzempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'

23.10.24ZacksThe Zacks Analyst Blog Highlights Novo Nordisk, Novartis, Pfizer, Regeneron Pharmaceuticals and Biogen

22.10.24ZacksWhy Novo Nordisk (NVO) Dipped More Than Broader Market Today

17.10.24ZacksThe Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNR

16.10.24BenzingaHere's How Much You Would Have Made Owning Novo Nordisk Stock In The Last 10 Years

16.10.24MotleyFoolEli Lilly vs. Novo Nordisk: Which Weight Loss Stock is The Better Opportunity Over The Next 10 Years?

15.10.24ZacksNovo Nordisk (NVO) Registers a Bigger Fall Than the Market: Important Facts to Note

15.10.24ZacksNovo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It

12.10.24MotleyFoolInterested in Weight Loss Stocks Besides Novo Nordisk and Eli Lilly? You Might Want To Check Out This New IPO Stock

11.10.24BenzingaNovo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names

10.10.24Financial TimesNovo Nordisk, Eli Lilly and the GLP-1 economy

Novo Nordisk (spons. ADRs) News

Novo Nordisk (spons. ADRs) News: auf dieser Seite finden Sie alle Novo Nordisk (spons. ADRs) News und Nachrichten zur Novo Nordisk (spons. ADRs) Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Novo Nordisk (spons. ADRs) News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Novo Nordisk (spons. ADRs) News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.